Therapeutics

Other

  • Study completed / Planned end date
  • Planned end date unavailable
  • Study aborted
Other 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
AC-1204
Phase 2/3
AGB101
Phase 2
Anavex 2-73
Phase 2
CHF 5074
Phase 2
Dexpramipexole
Phase 2
FRM-0334
Phase 2
Masitinib
Phase 2, Phase 3
NIC5-15
Phase 2
Pioglitazone
Phase 2, Phase 3
Piromelatine
Phase 2
Riluzole
Phase 2
Saracatinib
Phase 2
Sargramostim
Phase 2